Wiggin and Dana represented Affibody AB on the matter. Affibody AB has signed a collaboration and license agreement with Chiesi Farmaceutici S.p.A to discover, develop and commercialize innovative...
Affibody AB’s License and Collaboration Agreement with Chiesi Farmaceutici S.p.A
Affibody AB’s License and Collaboration Agreement with ACELYRIN, INC.
Wiggin and Dana represented Affibody AB on the deal. Affibody AB signed a partnership agreement with ACELYRIN, INC. to develop and commercialize izokibep, a bispecific molecule targeting interleukin-17A...